Liste de vérification
5 strategic considerations for launch planning in an MFN environment
As MFN policies and international reference pricing evolve, pharma manufacturers face new questions around launch sequencing, pricing, and market access. This practical checklist outlines five key considerations to help cross-functional teams assess risks, dependencies, opportunities, and readiness in a changing global landscape.
Preparing for launch in a connected pricing environment
Global pricing and reimbursement decisions are becoming increasingly connected across markets. As a result, launch planning may require earlier coordination between pricing, market access, regulatory, HEOR, and commercial teams.
This checklist provides a structured framework to help organizations evaluate:
- The potential impact of first-launch market selection
- Alignment across launch, pricing, access, and regulatory functions
- Alternative launch sequencing approaches
- Implications for patient access
- Readiness for an evolving policy landscape, including emerging initiatives that may influence pricing and access decisions
Whether preparing for an upcoming launch or reassessing commercialization strategies, this checklist offers practical questions to support informed decision-making and cross-functional planning. Use it to assess launch planning processes, evaluate first-launch market impact, alignment across functions, alternative sequencing scenarios, patient access implications, and readiness for an evolving pricing policy landscape.
